Caroline Germa, M.D.
Chief Medical Officer
Dr. Caroline Germa is an accomplished medical oncologist and clinical development leader with over 25 years of pharmaceutical industry experience across the spectrum of drug development, from early clinical trials to late phase and registrational studies. Prior to Ikena, Dr. Germa served as the EVP, Global Medicine Development, and Chief Medical Officer at Transcenta Therapeutics, where she played a pivotal role in shaping strategic goals for the company’s oncology and non-oncology portfolio, ensuring successful execution across all clinical development functions. In addition, Dr. Germa held senior leadership positions at global pharmaceutical companies such as AstraZeneca, Bristol Myers Squibb, and Novartis. Dr. Germa earned her Medical Doctor degree and board certification in medical oncology at the University of Lille, a degree in immunology from the University of Lille and a degree in health economics from Paris Diderot University in France.
